Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6484382 | Biomaterials | 2018 | 156 Pages |
Abstract
This review aims to give a comprehensive and critical update of the development of poly(2-oxazoline) based biomaterials, focusing on the last 5 years, which have seen an explosive increase of interest. We believe that the research regarding this diverse family of polymers will remain strong and will keep growing, in particular after the promising first-in-human studies of a poly(2-oxazoline) drug conjugate. This review aims at researchers and students new to this polymer family and seasoned poly(2-oxazoline) experts alike and attempts to showcase how the chemical diversity of poly(2-oxazoline)s allows a relatively facile and broad access to biomaterials of all kinds.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Thomas Lorson, Michael M. Lübtow, Erik Wegener, Malik S. Haider, Solomiia Borova, Daniel Nahm, Rainer Jordan, Marina Sokolski-Papkov, Alexander V. Kabanov, Robert Luxenhofer,